FDA Guidance for Industry
Date: April 25, 2023
The FDA has issued a final guidance to provide information on risk-based approaches to monitoring the conduct of clinical investigations of human drug and biological products, medical devices, and combination products.
Find out more.
Explore More News

Welcome Mednet as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Mednet as a new . . .
Read More

Welcome Allucent as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a . . .
Read More

Welcome KCR as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .
Read More

Welcome Debiopharm as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .
Read More

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025
The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .
Read More

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3
As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .
Read More

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines
The EMA has opened a public consultation on a reflection paper presenting views . . .
Read More

Welcome Instem as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .
Read More

Regulatory Considerations Expert Group reviews draft FDA Guidance
The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .
Read More

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review
The R&D industry, especially those that are working on clinical trials, have been . . .
Read More

Welcome Algorics as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .
Read More

Consultation response on legislative proposals for clinical trials
The MHRA have published the public consultation response to the proposals to reform the . . .
Read More